Aspirin aPL Primary Prevention — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Low-dose aspirin (75mg daily) is recommended for primary thromboprophylaxis in aPL-positive SLE patients who have not yet had a thrombotic event
EULAR 2019 APS/2023 SLE: low-dose aspirin for primary thromboprophylaxis in aPL-positive patients without prior thrombosis. Reduces first thrombotic event risk. For secondary prevention (after thrombosis) Warfarin INR 2-3 is standard. Adding HCQ further reduces thrombotic risk.
Reference: EULAR 2019 APS; EULAR 2023 SLE